Terran Biosciences
- Biotech or pharma, therapeutic R&D
Clinical-stage CNS-focused biotech company developing novel therapeutics for schizophrenia, including TerXT, a combination of novel prodrugs of xanomeline and trospium, designed to enable once-daily oral dosing and an intramuscular injectable form with a multi-month duration.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}